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ABSTRACT 
Concanavalin A (Con A) is a lectin or carbohydrate binding protein having broad range of 
significant biological functions such as anti-tumor, anti-viral, anti-inflammatory, anti-
proliferative activities. The current study intends to focus on the role of Con A in cell death 
mechanisms autophagy and apoptosis in oral cancer cell line Hep-2. The acridine orange 
staining demonstrates that Con A is able to induce oral cancer cell autophgy. The ability of 
con A to induce apoptosis was studied using various staining procedure such as DAPI, 
Annexin V-FITC staining and Caspase-3/7 Glo assay. Additionally how chloroquine 
possesses the potential to inhibit the autophgic activity of con A has also been studied. As 
conclusion, the molecular mechanism of Con A induced cell death by autophagy followed to 
apoptosis in oral cancer has been well discussed, which will lead to opening of new 
perspectives for Con A as potential anti-cancer drugs in future oral cancer therapeutics. 
Key words: Lectin, Con A, Cancer, Apoptosis, Autophagy  
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1. INTRODUCTION 
Lectins are carbohydrate binding proteins which are non-immune in origin and specifically 
recognise the carbohydrate moieties. They bind with carbohydrates both reversibly and non-
covalently.  “Lectin” is derived from the Latin word “Legere”, means “to select” The ability 
of reorganisation and binding of specific carbohydrate structures is the biological function of 
lectins (
1
Goldstein et al., 1980). Not only lectins distinguish between different 
monosaccharide but they specifically bind to oligosaccharides also, by detecting suitable 
difference in complex carbohydrate structure. So far the function is concerned lectins can be 
differentiated according to their recognition to endogenous or exogenous ligands. Lectins 
recognizing endogenous ligands play a job in fertilization and development and sometimes 
their function also involves in cell-to-cell or cell-to-matrix interaction (
2
Sharon, N. Lis,H.; 
1989).  Another type of lectins which recognizing exogenous ligands are evolved for non-self 
discrimination and they might be soluble or surface bound. The main function of lectin in 
animals is cell adhesion to glycoprotein synthesis. Some lectins which are found on surface 
of liver cells in mammals for recognized galactose residues. In immune system their function 
is reorganisation of carbohydrates and found on pathogens or these are inaccessible on host 
cells. Lectins are used in various purposes specifically for medicine and medical research. 
Purified lectins are used for blood typing as clinical research. Lectins have been widely used 
as the molecular basis of protein recognizes carbohydrates. Another important type of the 
lectin family is the Legume lectins, which is mainly found in the seed of the legume plant. 
This legume lectin plays a potential role in cancer treatment (
3
Gabius et al., 2011).  
1.1. Role of lectins in cancer treatments:  
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Plant lectins have a potent biological activity, which contain a unique group of proteins and 
glycoproteins generally found in foods like wheat, pea, tomato, corn, peanut, kidney bean, 
banana, soybean. Several lectins have anticancer properties which were found in-vitro, in-
vivo and in human case studies. They are used as therapeutic agents when binding to cancer 
cell membranes and their receptors. It causes cytotoxicity, apoptosis, and also inhibition of 
tumour growth by altering the production of various interleukins or by activating protein 
kinases. They can also modify the cell cycle by inducing non apoptotic G1 phase mechanism, 
G2/M phase cell cycle arrest and apoptosis. It can downregulate telomerase activity and also 
inhibit angiogenesis. Thus lectin seems to have great potential as anticancer agent. 
1.2. Description of jack-bean 
Canavalia ensiformis is a legume crop, commonly known as jack bean which is used for 
animal food and human nutrition. It is a climbing perennial legume commonly cultivated as 
annual. The height of the plant is up to 2m with 8-20cm long trifoliate leaves. This plant has 
strong root system and the flowers are pink or white with a red base. Pods are up to 36 cm 
long and contain ellipsoid seeds which have 1-2cm long. Pods and seeds are edible and used 
for food. The whole plant is also used to feed animals. 
1.3. Distribution 
Jack bean was originated in Central America and west-indies. Now it is widely distributed in 
tropical and subtropical regions. This crop was cultivated in worldwide from united state, 
Brazil, Argentina, China and India. In Brazil it is called as “pig bean”. It was used for tropical 
soil reclamation efforts and avoiding the wide range of soil acidity, salinity condition. It has 
also capable of nitrogen fixation. Mainly jack beans were free from pets and disease. Jack 
bean has also reported as antagnostic or suppressive of nematodes. These legume plants are 
not cultivated commercially because the beans are mildy toxic in nature and copious 
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consumption must be avoided. Jack bean is the main source of concavalin A, a lectin used for 
several applications.  
 
 
Classification of Canavalia ensiformis: 
Kingdom Plantae 
Sub-Kingdom Tracheobionta 
Super-Division Spermatophyta 
Division Magnoliophyta 
Class Magnoliopsida 
Sub-Class Rosidae 
Order Fabales 
Family Fabaceae 
Genus Canavalia 
Species ensiformis 
Table-1: Sytemetatic classification of Jackbean (Canavalia ensiformis) 
 
 
        Figure 1: Jackbean tree with pod                     Figure 2: Jackbean seed 
1.4. Concanavalin A 
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Concanavalin A (Con A) is a lectin or carbohydrate binding protein. It is a member of legume 
lectin family, originally extracted from the seeds of Jackbean (Canavalia ensiformis). It was a 
single protein having three dimensional structures. It binds to certain structures specifically 
found in various sugars, glycoproteins, and glycolipids, basically internal and terminal non 
reducing α-D-mannosyl and α-D-glucosyl groups of sugars (4Goldstein and Poretz, 1986). It 
was the first lectin to be available on a commercial basis. It is widely used in biology to 
characterize glycoproteins and other sugar binding proteins. It is also used to purify 
glycosylated macromolecules in lectin affinity chromatography in addition to study immune 
regulation by various immune cells. 
1.5. Characteristics of Con A 
Con A is a representative member of legume lectin class of plant protein. It is a homotetramer 
having subunit 26.5KDa and consists of 237 amino-acids residues, but it does not contain any 
cysteine residues (
5
Olson and Liener 1967). It binds with metallic atom usually Mn
2+
 and a 
Ca
2+
. Con A interacts with metals on the molecular basis as well as its affinity for sugar 
molecules. Con A exists as a dimer or tetramer (Loris et al, 1998) and also exists as a 
dimetallised dimer. The molecular weight is about 104-112KDa. It is a plant mitogen and has 
the ability to activate mouse T-cell subsets which gives rise to four T-cell populations like 
precursor and suppressor T-cell (
6
Powell and Leon 1970). One subset of human suppressor T-
cell is most sensitive to Con A. Con A can initiate cell division by stimulating the energy 
metabolism of thymocytes, principally acting on T- lymphocytes. It can also use in specific 
binding action with carbohydrate containing receptors. 
1.6. Structure of Con A 
Con A was the first lectin whose structure was known. It has a three-dimensional structure 
with tentative amino-acid sequence (
7
Bruce A et al, 1972). It is a homotetrameric subunit 
(26.5kDa). The protein consists of 237 glycated amino acids and has two metal binding sites 
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i.e. Ca²+ (an ion) or Mn²+ (a transition metal) (Min W et al, 1972). According to structural 
feature the amino acid chain contains two anti- 
parallel beta sheets. Out of the two beta sheets one is built from seven bands and other one 
contains six strands. In its active state ConA forms aggregates. After joining two six stranded 
sheets resulting as a dimeric molecule (twelve stranded sheets). Two dimers form a functional 
complex by layering side to side. The final complex contains four spatially well separated 
binding sites for oligosaccharides.          
                             
                                            
                                                                                                                                                                                                       
 
 
 
                           
Figure 3: Homotetrameric structure of concanavalin A 
1.7. Biological activities of Con A 
The monomer of Con A is called as ‘jelly roll’ motif composed of two anti-parallel sheets. 
Con A was interacting with both carbohydrate containing mannose and also with rhodopsin, 
immunoglobulins, lipoproteins and carcino-embryonary antigen. It has been observed that 
tryptophan and tyrosine residues are involved in binding of carbohydrates. Preferably, it can 
agglutinate red blood cells and cancer cells. When transformed T cells and normal cells were 
treated with trypsin, they do not agglutinate at 4°C rather they agglutinate in the presence of 
con A. Joining of six strands form a diamer. Two diamers then form a complex by layering 
twelve stranded sheets. Thus four separate binding sites for oligosaccharides are formed and 
they are able to agglutinate cells like erythrocytes, myocytes, B-lymphocytes, fibroblasts, 
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human fetal, ratthymocytes, intestinal epithelial cells, adipocytes etc. Con A can stimulate 
several matrix metalloproteins (MMP) (
8
Wecksler, M., et al., 1968). It has a high 
agglutination activity towards cancerous cells or transformed cells but no agglutination effect 
in normal cells (
9
Inbar and Sachs, 1969). Excess amount of Con A can be harmful for the 
organisms because it is toxic in nature and toxicity of Con A can triggers apoptosis and 
autophagy in cell. By this mechanism, Con A is responsible for killing the cancer cells by 
inhibiting the activity of DNA polymerase alpha, by which the further replication process was 
blocked and then stopped cell division. 
1.8. Application of Concanavalin A 
Con A, the novel lectins have several applications in many aspects. The identification of first 
lectin is Con A, which is a macromolecular mitogen. Con A binds with saccharides by 
forming hydrogen bonds like other saccharide binding proteins (Quiocho 1986). 
Concanavalin A is also used to study for the relationship between cell toxicity and 
aggregation process. Con A has anti-proliferative activity on human cancer cells. It can also 
induce cancer cell death through apoptotic and autophagic pathway. In apoptosis process it 
lacks function of p53 and in autophagic pathway through mitochondrial process. It can induce 
human melanoma A375 cell in caspase-dependent manner that means in autophagic pathway 
(Liu B et al, 2009). It was recently reported that Con A has anti-hepatoma (liver cancer) 
effect (
10
Lei HY, and Chang CP 2009).  Con A can use to immobilize the glycoenzymes, 
because in traditional covalent coupling they face several difficulties to immobilize them.  It 
was used in immuno-electrophoresis for detecting the hormone associated variation in α1 
acid glycoprotein (Christine wells et al, 1980). 
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2. REVIEW OF LITERATURE 
Concanavalin A (ConA), the first well-known representative of legume lectin family, has 
increases the attention because of the interesting biology effects. Because of specific binding 
properties of carbohydrate, Con A has several aspects in several fields. Starting from 1916 to 
Now a Days there are several researches on Con A. Con A history was started from 1916 
(Jones, D.B.; Johns, C.O. ; 1916). In this year isolation of two globulins from jack bean were 
studied. Then in 1936, by crystallization and purification it was identified that Con A was the 
first legume lectin. Further research on Con A in 1936 confirmed that lectins were 
carbohydrate-binding proteins and Con A was very specific for glucose and mannose 
(
12
Sumner, J.B.; Howell, S.F.; 1936).  The primary and three-dimensional structures of Con A 
were resolved in 1972 (Hardman, K.D.; Ainsworth, C.F.; 1972).  Then in 1982 it was 
demonstrated that Con A depend upon metal ions (Hardman, K.D. et al., 1982).  Later in 
1985, biosynthesis and molecular cloning of Con A was performed (Carrington et al., 1985). 
Con A induced apoptosis in fibroblasts was reported in 1995 and carbohydrate-binding 
property of Con A was intimately associated with apoptosis-inducing activities (
13
Kulkarni et 
al., 1995). Until 2007, it was demonstrated that Con A-induced autophagy through 
mitochondrial pathway (Fig.4). 
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Figure-4: The timeline of Con A 
Con A is a prospective anti-neoplastic agent for cancer therapeutics by targeting apoptosis 
and autophagy. Apoptosis, the self-killing process and autophagy,  the self-eating process are 
two important cell death mechanisms.  
2.1. Programmed Cell Death: 
 Programmed cell death (PCD) is a death of a cell by any form in a regulated process. PCD is 
an evolutionarily conserved process which helps to decide about cell fate. PCD is a intrinsic 
mechanism of cells which plays a vital role for eliminating harmful cells and maintaining 
homeostasis. Mainly there are two forms of PCD i.e. apoptosis and autophagy. There are two 
types of PCD, type I (apoptotic cell death) and type II (autophagic cell death). There are also 
several other mechanisms such as necrosis, msenescence, and mitotic catastrophe. 
I. Type I Programmed Cell Death.  
The type-I apoptotic cell death is a form of PCD characterised by several morphological 
features such as chromatin condensation, nuclear fragmentation, membrane blebbing, cell 
shrinkage and apoptotic body formation. Apoptosis is a caspase dependent process. There are 
two main pathways in apoptosis, extrinsic and intrinsic. Extrinsic pathway is a receptor 
mediated pathway where as intrinsic pathway is a mitochondrial mediated pathway. 
II. Type II Programmed Cell Death.  
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Apoptosis, the type-II programmed cell death is a catabolic process which involves 
degradation of cells own component by lysosomal process. Mechanism of autophagy 
involves isolation of membrane formation then it identifies the cellular components for 
degradation. By this process autophagosome formation comletes and fuses with lysosome to 
form autophago-lysosome or autolysosome which degrades the cellular components. 
The above three mechanisms apoptosis, autophagy, and necrosis  are being interconnected 
with each other. (
14
Vassiliki Nikoletopoulou et al., 2013). Interaction between these three 
mechanism control whether a cell lives or dies (fig-3). Any de-regulation of this mechanism 
may lead to several diseases and it may also alter the characteristics of cell death.  
                        
Figure-5: Cell death mechanism 
2.2. Autophagy 
Autophagy, the “self eating” process is a cell death mechanism, which degrades the 
unnecessary components of cells. Autophagy is a regulated process of degradation and 
recycling of cellular constituents and it can also participate in organelle turnover. It serves as 
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a protective role by allowing cells to survive during nutrient starvation. It is an important 
mechanism of cellular self-degradation. Autophagy plays an essential role in cellular and 
whole-animal homeostasis and differentiation.  Autophagy, a dynamic pathway is controlled 
by several genes and the genes are connected each other by autophagosome formation. It is a 
nonselective degradation process which directly engulfs the cytoplasmic organelles 
(
15
Johansen and Lamark 2011). Deregulation of autophagy may contribute many diseases 
like ageing, neuro-degeneration, tumour, heart disease, lung and liver diseases and many 
other diseases  (
16
Levine and Kroemer 2008; Mizushima and Yoshimori 2007).  Therefore it 
is important to characterize this process at the molecular level.  
2.3. Types of autophagy 
There are mainly 3 types of autophagy such as microautophagy, macroautophagy and 
chaperone-mediated autophagy (CMA).  
CMA is the mechanism which allows the degradation of cytosolic proteins and organelles. 
 In this process, first the soluble cytosolic proteins are targeted to lysosomes, then removes 
through lysosomal membrane by translocation. Mostly CMA is studied in the mammalian 
cells for concerning pathogenesis of different diseases. This is activated in response of stress 
like oxidative stress and exposure to toxic materials (
17
Kaushik and Maria 2012). 
Macroautophagy is a vital process in the eukaryotic cells. This process controls the 
arrangement and sequestration of the cellular components which need to be recycled by 
lysosome (Kanazawa et al. 2003; Wang and Klionsky 2003). In mammalian cells, this 
process is activated by lower insulin level (
18
Mortimore et al. 1989; Mortimore and Poso 
1987; Seglen and Bohley. 1992). Previously it is reported that the micro- or macro-autophagy 
can occur both in the same organism and also same time, such as the mitochondrial selective 
degradation (Kissová et al. 2007). Macroautophagy simply referred as autophagy which is a 
lysosomal degradation pathway. 
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Microautophagy is described as a nonselective lysosomal degradative process (Dice, 2007). 
It is a form of autophagy involving turnover of long-lived proteins, while substrate soluble 
microautophagy can be activated by rapamycin through regulatory signaling complex 
pathways (Dalibor et al. 2011). 
 
 
Figure-6: Autophagy mechanism 
2.4. Autophagy and cancer 
Autophagy plays an important role in cancer. Cancer is a generic disease having uncontrolled 
proliferation of cells. Autophagy is a critical mechanism for cancer cells because these cells 
required large amount of energy for cell growth (
19
Levine, B., 2007). On one hand, 
deregulation of autophagy may lead to genomic instability and this process promotes the 
tumour initiation and progression of autonomous tumour cells. In other case autophagy 
defects may lead to several alternations in cells like tumour cell survival in stress condition, 
necrotic cell death, inflammation etc. Cytokines are generated through inflammation which 
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helps in promoting tumor cell growth.  Hence autophagy acting an important role both in case 
of cell survival and the death of the cells (
20
Liu, B et al., 2009). 
2.5. Autophagic pathway for cancer therapy 
There are several methods for prevention of cancer by targeting the autophagy pathway. If we 
can identify autophagic pathway which is required for the suppression of tumorigenesis, then 
for cancer therapy autophagy can act as a new target. 
I. Inhibitor of autophagy blocks metabolic stress of cell survival 
Autophagy inhibitors can target tumour cells in hypoxic tumour regions, so that these are 
particularly attractive for cancer therapy. Tumour cells may also particularly dependent on 
autophagy in the process of metastasizing. 
II. Inhibition of apoptosis 
An alternate approach for cancer therapy is the inhibition of apoptosis. There are various 
protein families which plays major role in inhibiting apoptosis. Apoptotic inhibitors are class 
of proteins which inhibits apoptosis. For example: Bcl-2 is a apoptotic inhibitor which 
inhibits apoptosis. For this mechanism Bcl-2 requires Bim, the pro-apoptotic protein. 
Additionally Bax and Bak are required for this process. So these apoptotic inhibitors plays a 
novel role in anti-cancer properties. 
III. By developing autophagic inhibitors 
Activation of autophagy and autophagosome formation is regulated by kinases (Atg1/Unc-51, 
vsp34), proteases (Atg4) and two ubiquitin like conjugation system. There are also signalling 
pathway that regulate activation of autophagy i.e. both mTOR-dependent and –independent 
(mammalian target of rapamycin). For autophagy inhibitor development, signalling pathway 
are good candidates, because they promote autophagy. For example, hydroxychloroquine 
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(HCQ) is an autophagy inhibitor, which blocks lysosome acidification and autophagosome 
degradation, which enable assessment.  
2.6. CROSS TALK BETWEEN AUTOPHAGY AND APOPTOSIS: 
Apoptosis, a programmed cell death is characterized by cell death through morphological 
changes, including shrinkage of nucleus, fragmentation, chromosomal DNA fragmentation, 
and chromatin condensation. Number of diseases results in the defective apoptosis like 
atrophy, which is the result of excessive apoptosis. But in cancer the insufficient amount 
results unrestrained cell proliferation.  Apoptosis and autophagy are connected with each 
other by several processes.  Autophagy can provide a foundation for apoptosis while the 
pathway of apoptosis can be delayed by the inhibition of autophagy (
21
ShuYan et al. 2014). 
Autophagy and apoptosis are two important cellular processes having a complex protein 
networks. For example, Bcl-2 is a protein which acts as a central regulator for both apoptosis 
and autophagy mechanism (Table -2). 
Bcl-2 inhibits autophagy when it is localized to the endoplasmic reticulum and mitochondria. 
Autophagy and apoptosis are triggered by the displacement of Bcl-2 from Beclin-1during 
Cellular stress. BH3-only proteins and post-translational modification can disrupt the 
complex through autophagy and apoptosis mechanism (
22
Chun-Yang Li et al., 2010). There 
are several autophagic proteins which are which regulate both extrinsic as well as intrinsic 
apoptosis. For instance, calpain- and caspase-mediated cleavage of autophagy-related 
proteins can switches the cellular program from autophagy to apoptosis. This highlights a 
dual cellular role for autophagy.  Autophagy degrades caspases and the damaged 
mitochondria. It also provides a membrane-based platform for caspase processing for 
apoptosis regulation. The crosstalk between autophagy and apoptosis is complex, and this 
crosstalk is critical to cellular fate. In certain cellular conditions, autophagy can promote cell 
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survival and avert apoptosis, and in some other cases autophagy may lead to cell death 
(
11
Huan-Yao Lei* and Chih-Peng Chang ., 2009).  
Table-2: Role of proteins in both autophagy and apoptosis (Mukhopadhyay, S., et al., 2014). 
mTOR Inactive form involves in initiation mTOR regulates apoptosis 
 
Beclin-1 
Autophagosome nucleation Cleaved C-fragment induces 
mitochondrial apoptosis 
 
UVRAG 
Upregulates Vps34–Beclin1 
interaction 
Antiapoptotic, inhibits Bax 
translocation from cytosol to 
mitochondria 
AMBRA Upregulates Vps34–Beclin1 
interaction 
Regulate mitochondrial apoptosis; 
cleaved by caspases and calpains 
Atg3 Conjugates with Atg12 Regulates mitochondrial cell death 
Atg5 Conjugates with Atg12, 
autophagosome elongation 
Interacts with FADD to inhibit 
apoptosis, cleaved N-fragment 
induces mitochondrial apoptosis 
Atg12 Autophagosome elongation Stimulates mitochondrial apoptosis 
by inactivating Bcl-2 and Mcl-1 
Atg4D LC3 processing Cleaved Atg4D localize to 
mitochondria and induces apoptosis 
APOPTOTIC PROTEINS 
Bcl-2  Inhibitor of autophagy Anti-apoptotic 
Bad, Bak, Pro-autophagic, disrupting Beclin-1/Bcl-2 interaction Pro-apoptotic 
           PROTEIN ROLE IN AUTOPHAGY ROLE IN APOPTOSIS 
AUTOPHAGIC PROTEINS 
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BNIP3, Nix 
Bax, PUMA Proautphagic, noncanonical type Pro-apoptotic 
p53 Inhibits by cytoplasmic p53 Pro-apoptotic 
Noxa Induces autophagy by disrupting Mcl-1/Beclin-1 
interaction 
Pro-apoptotic 
Bim Sequesters Beclin-1, inhibits autophagy Pro-apoptotic 
XIAP Inhibits by Mdm2-p53 signalling Inhibits caspase 
3,7 
cFLIP Prevent interaction between Atg3 and LC3 Inhibits casepase 8 
 
2.7. Con A induced Autophagy and related molecular mechanisms 
Previously it was reported that Con A has specific sugar binding residues, this property helps 
to induce cell death. In case of tumour cell lines, cytotoxic casues at high concentration 
where as at low concentration it is cytoatatic (
23
Rubinsztein et al., 2007). After binding with 
mannose moiety, Con A was internalized to the mitochondria, and then the autophagic cell 
death was initiated through clathrin-mediated endocytosis (
24
Lei, H.Y. et al., 2009).  
 It was shown that Con A treatment with CT-26, ML-1 cell line there were many autophagic 
pathway observed, these are, formation of LC3-II, vesicles with double-layer and induction 
of BNIP3. In case of  ML-1 cells it noticed that autolysosome formation was takes place 
which indicates that Con A induced autophagy (
25
Lei, H.Y. et al., 2007).  Autophagy induced 
by Con A is an autophagic flux. It was observed that in hepatocellular cells Con A induced 
autophagy. But these were not observed in oral cancer cell lines (Chang, C.P. et al., 2007).  
Apart from this, Con A also serves as T cell mitogen modulating immune system. Production 
of cytokine inside the tumor was activated when Con A induced immune system in hepatoma 
cell. Then lymphocytes were needed, which further gave rise to the elimination of the tumor. 
24 
 
 
 
2.8. Con A induced apoptosis and related molecular mechanisms 
From previous report, it was found that Con A induce apoptotic cell death  (
26
Chen, M et al., 
2002). It was indicated that Con A at this concentration acted as T-lymphocytes and 
thymocytes mitogen (
27
Cribbs, D.H. et al., 1996). Con A was specifically binds with lectin 
and receptor glycoprotein. When neurons treated with Con A there was seen many 
morphological changes in the cell, including membrane blebbing, chromatin condensation 
and many others. These changes were later proved as typical features of apoptosis (Cribbs, 
D.H. et al., 1996). After ConA treatment this experiment also observed increase in 
immunoreactivity for c-Jun [36]. Now c-Jun involved in the process of apoptosis (
28
Krens, 
S.F. et al., 2006). When central nervous system is injured, the astrocytes in human brain can 
form glial scar to prevent neuronal regeneration (Gabryel, B. et al., 2001). Con A was 
exposed to bind with astrocytes and triggering apoptotic cell death. This binding occurs due 
to the carbohydrate binding activity of Con A (
29
Yoshida, H. Et al., 2009).  These findings 
provide possible mechanism for treating injured nervous system through mediation of 
apoptosis.  
Another research reported that Con A has anti-proliferative activity. Con A was positively 
correlates with its sugar-binding and hemagglutination activitie (Liu, Z.Y. et al., 2010). A 
tumour suppressor gene, p53 regulates cell cycle and apoptosis. But it is often mutant in 
cancer cells (
30
Harris, S.L. et al., 2005).  Further it was indicated that Con A treatment caused 
an initial G2/M delay followed by G1 arrest (Amin, A.R. et al., 2007). Lacking p53 cells 
undergo apoptosis, and the cells with p53 were protected by arresting in G1 phase. It was also 
investigated that Con A-induced expression of p73 was independent on E2F1. But it was 
regulated by reactive oxygen species (ROS) and for the first time confirmed that Con A could 
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activate p21, cdk inhibitor through p73-dependent manner (Amin, A.R. et al., 2010). In tumor 
cells, the induction of apoptotic cell death would serve as an effective cancer therapy agent. 
Because of this remarkable apoptosis-inducing activities Con A has been drawing rising 
attention towards the autophagy and apoptosis. 
2.9. Con A has anti-proliferative activity  
Con A  has been drawing rising attention for its potential applications in cancer therapeutics. 
Recent studies shows that Con A with mannose/glucose specificity has anti-tumour activity. 
Further experiment on Con A proved that the antiproliferative activity was influenced by 
hemagglutination (
31
Bo Liu et al., 2009). Con A has specific sugar binding activity which 
overlaps the hemagglutinating active centre and it was indicated by the carbohydrate-binding 
activity assay. Hence, Con A shows a major effect in anti-proliferative activity due to its 
carbohydrate binding nature. 
2.10. Chemoprevention nature of Con A 
Con A is toxic in nature and its toxicity property can triggers both autophagy and apoptosis in 
cancer cells. In case of animals when lectins are orally injected, it causes intoxification 
(
32
Liener IE., 1995). There are several plant extracts which are used in adjuvant cancer 
therapy by injected it. For instance, in Europe Mistletoe, the galactoside-specific lectin is 
used for the alternative treatment for cancer. In case of soybeans, there are many anti-
carcinogenic phytochemicals are present. (
33
Schumacher K et al., 2003; de Mejia EG et al., 
2003). Previously it was also reported that in boby system Con A can inhibits  liver nodule 
formation by oral injection. This indicates the chemopreventive nature of Con A for cancer 
treatment (
34
Rosenberg SA et al., 2004). Con A-like substances, particularly natural 
substances like edible vegetable plants, seeds and health foods have both immunomodulating 
and autophagy-inducing activities.  
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OBJECTIVES 
1. To determine the morphological changes of Hep-2  cells by 
Bright field microscope 
Tryphan blue Exclusion Assay 
2. To study con A induce autophagy in Hep-2 cells by  
Acridine orange staining 
3. To determine apoptotic cell death by 
DAPI staining  
Annexin V FITC staining 
Caspase-3/7 Glo Assay 
4. To study the relationship between autophagy and apoptosis 
by Chloroquine treatment 
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3. MATERIALS AND METHODS 
3.1. SAMPLE COLLECTION: 
The Canavalia ensiformis (jack-bean) seeds were collected from Angul, Odisha, India. 
Con A, a lectin from jack bean seeds were previously extracted in the laboratory of Cell and 
Cancer Developmental Biology (CCD-lab), NIT Rourkla, Odisha, India. 
3.2. CHEMICALS: 
Sodium carbonate (Na2CO3), Sodium hydroxide (NaOH), Cupper sulphate (CuSO4), 
Glycine, Potassium sodium tartarate (KNaC4H4O6) were purchased from SRL, Sisco research 
laboratories Pvt. Ltd., Mumbai. Ammonium per sulphate (APS), Acrylamide, bisacrylamide, 
Sodium dodecyl sulphate (SDS), ethanol, Bovine serum albumin (BSA), N, N, N’, N’-
tetramethylenediamine (TEMED), and Tris were purchased from Sigma Aldrich, USA. 
Potassium hydrogen phosphates (K2HPO4), Potassium Dihydrogen Phosphate (KH2PO4), 
were purchased from S.D. fine chem. Ltd., Mumbai. Glycerol was purchased from RANKEM 
Pvt Ltd. Ethanol was from Trimurty Chemicals, India. Acetic acid, Bromophenol blue, 
Typhan blue and agarose were purchased from Himedia, Mumbai. Cell culture media viz. 
MEM, DMEM were purched from the Gibco. Silver nitrates, Sodium thiosulphate, Methanol, 
were purchased from nice chemicals Pvt .Ltd. India. Pre stained molecular weight marker 
were purchased from Bio-Rad, India. Trypsin & antibiotics were purchased from the Hi-
media. Acridine Orange, DAPI and Annexin V-FITC were purchased from the Sigma. T25 
and T75 cell culture plates were purchased from tarson, India. 
3.3. Cell line: 
The whole experiment was carried out by using the oral cancer cell line HEp-2, which was 
collected from National Center for Cell Science (NCCS), Pune. 
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3.4. Cell viability assay:  
Principle: 
Cell Viability is the test to determine the ability of cells to maintain its viability. There are 
several assays or test used to determine the cell viability. For example: by using propidium 
iodide (PI), typan blue etc. Here, simply using bright field microscopice, the number of viable 
cells was determined. 
Methods: 
Preseeded HEp-2 cells were treated with Con A and kept incubation for 24 hrs. After that 
visualisation study was done under microscope. 
3.5. Trypan blue exclusion assay: 
Principle: 
The trypan blue exclusion test is used to determine the number of viable cells present in a cell 
suspension. The principle behind this test is that live cells exclude certain dyes like trypan 
blue because of intact cell membrane. But the dead cells take up the dye because of inability 
to exclude the dye. This test is used to determine whether the cells either take up the dye or 
not.  
Methods: 
Cell suspension aliquot was tested for viability for 5 min at 100×g. Then it was centrifuged 
and supernatant was discarded. Aliquot size depends upon the number of cells present in that 
cell suspension. 0.4% trypan blue was mixed with 1 part of the cell suspension. Then observe 
under microscope. The viable cells have a clear cytoplasm where as the non-viable cells have 
a blue cytoplasm. The percentage of cell viability is determined by counting both the viable 
cells and non-viable cells. 
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3.6. Acridine orange staining  
Principle: 
Acridine orange (AO) is a nucleic acid selective fluorescent cationic dye. AO is useful for 
cell-cycle determination and it is cell permeable. It interacts with both DNA and RNA. It 
crosses into lysosomes and other acidic compartments and becomes protonated. AO is used in 
autophagic assays and is characterized by rising formation of AVOs (acidic vesicular 
organells) viz. lysosomes and autophagolysosomes. After staining the cells with AO, AVOs 
can be quantified by flow cytometry. AO is a weak base that accumulates in acidic spaces 
and produce red fluorescence. AVOs can be quantified with increasing the intensity of red 
fluoresce which is proportional to the degree of acidity. 
Methods: 
Cells were seeded in a 12-well plate. Then cells were treated with different concentrations of 
Con A for 24 hours. After that, acridine orange (AO) was added at a final concentration of 
0.5µg/ml for 15 min. Then observation was carried out under the fluorescence microscope 
(Olympus IX 71). 
3.7.  DAPI staining: 
Principle: 
4', 6-diamidino-2-phenylindole, DAPI is a fluorescent stain. It binds strongly to A-T rich 
regions in DNA. DAPI, the nucleic acid stain preferably stains dsDNA. DAPI can pass 
through an intact cell membrane, so that, it can be used to stain both fixed and live cells. 
DAPI, the blue fluroscent probe, fluoresces brightly upon the minor groove of dsDNA and its 
fluroscence is approximately 20-fold greater than the non bound state. At 460 nm, the DAPI 
shows fluorescence in dsDNA. High cell permeability allows efficient DAPI staining of 
nuclei with the little background of cytoplasm. For immunofluroscence microscope it is a 
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classic nuclear counter stain. Cells undergoing apoptosis shows several features such as 
reduction in cell-size, chromatin condensation, membrane blebbing, and nuclear shrinkage. 
Formation of apoptotic body by this process can be detected under the fluorescence 
microscope using appropriate staining of nuclei with DAPI. The effectiveness of this stain is 
less because in live cells the efficiency of passing through the membrane is less. 
Methods:  
Preseeded cells were treated with con A at various concentrations followed by incubation for 
24 hrs. Then the old media was discarded and cells were treated with paraformaldehyde for 
30 minutes at 37
0
C. Then washing with PBST and PBS was done for twice. In next step 
DAPI was added to the cells in dark room and incubated for 5 minutes. Again the cells were 
washed with PBS for three times. Then samples were studied under Olympus 1X71 
microscope. 
3.8. Annexin V-FITC staining 
Principle: 
FITC Annexin V staining can identify apoptosis at an earlier stage. Apoptosis is a normal 
physiologic process for removal of unwanted cells and it maintains tissue homeostasis. There 
are certain morphological features which are seen in case of apoptotic programme such as 
loss of plasma membrane asymmetry, chromatin condensation and nuclear shrinkage. From 
the above features, in apoptotic cells loss of plasma membrane was seen earliest. The 
membrane phospholipid phosphatidylserine (PS) is translocated from the inner to the outer 
leaflet of the plasma membrane of apoptotic cells. Thus, it exposes PS to the external cellular 
environment. Annexin V is a Ca
2+
 dependent phospholipid-binding protein having molecular 
weight 35-36 kDa. It has a high affinity for PS, and binds the cells with exposing PS. 
Annexin V may be conjugated with Fluroescien Isothiocyanate (FITC) to level PS on 
membrane surface. FITC Annexin V causes the loss of membrane integrity and by which cell 
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death occures by two processes apoptosis and necrosis. Hence, FITC Annexin V staining is 
usually used in combination with a vital dye like propidium iodide (PI). This process allows 
the researchers to identify easily the apoptotic cells and the results will be PI negative, FITC 
Annexin V positive. 
Methods: 
Cells were seeded in 12-well plates and treated with different concentrations Con A and kept 
for 24 hrs. Then the cells were washed with PBS and 1X Annexin V binding buffer was 
added followed by addition of Annexin V-FITC stain and incubated for 15 mins. Then 
observed in fluorescence microscope. 
3.9.  Caspase-3/7 Glo Assay:  
Principle: 
The Caspase- 3/7 Glo Assay is a homogeneous, luminescent assay which measures caspase-3 
and -7 activities. Caspase undergoes the member of the cysteine aspartic acid-specific 
protease family, which plays a vital role in apoptosis in case of mammalian cells. Caspase-3/7 
substrate contains the tetrapeptide sequence DEVD. Amount of caspase activity present is 
proportional to the Luminescence. The Caspase- 3/7 Glo Reagent relies on the properties of a 
thermo-stable luciferase enzyme, which is formulated to generate a stable “glow-type” 
luminescent signal and improves performance across a wide range of assay conditions. The 
Caspase Glo-3/7 Assay is showing caspase activity or apoptosis. 
METHODS 
In this assay total volume of 100µl used in 1:1 ratio of caspase-3/7 Glo reagent volume to 
sample volume. The substrates required for this assay are proteins, lysis buffer and caspase-
3/7 reagent. Protein was estimated by barford’s method. After estimated 25µg protein was 
mixed with cell lysis buffer. Then caspase-3/7 Glo reagent was mixed with the solution and 
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makes the volume 100µl. After 6-8 hrs incubation in dark reading was taken in promega 
20/20 luminometer. 
4. RESULTS AND DISCUSSIONS 
4.1. Cell viability assay 
 
Fig-7: Showing cell viability test 
INFERENCE 
From the above figure it was inferred that as the concentration of Con A increases in a dose 
dependent manner in Hep-2 cells, the number of cell death increases accordingly, So that the 
number of viable cells decreases in a dose dependent manner.  
4.2. Trypan blue exclusion assay 
INFERENCE: 
In this trypan blue exclusion essay (fig. 8), the cytoplasms of non-viable cells are in blue 
colour because trypan blue is being taken by these cells. But the viable cells have clear 
cytoplasm because the cells don’t take up the dye due to cytotoxicity nature of Con A. Thus it 
was shown that the % of viability of Hep-2 cells decreases in a dose dependent manner with 
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Con A treatment (Table-2). The % of cell viability was calculated by the no. Of viable cells 
divided with total no. Of cells then multiply with 100. (Fig-8) 
 
 
Fig-8: Graph showing % of viable Hep-2 cells after Con A treatment 
4.3. Acridine orange staining 
INFERENCE 
It was inferred that when Hep-2 cells are treated with different concentrations of con A in a 
dose dependent manner, the redness level increases accordingly. The shift of redness 
increases with increase the dose of Con A which indicates the formation of autolysosome.  So 
in higher dose i.e. in 100µg/ml there is more redness level which shows more autophagy in 
Hep-2 cells (Fig-9). 
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Fig-9: Showing acridine orange staining in Hep-2 cells after Con A treatment 
4.4. DAPI Staining 
INFERENCE 
As the dose of the Con A increases in Hep-2 cells it was seen that the chromatin condensation 
and nuclear fragmentation also increases. At higher dose (100µg/ml) con A, more nuclear 
changes occur which depicting the apoptosis. (Fig-10). 
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Fig-10: DAPI staining showing nuclear changes 
4.5. Annexin V-FITC Staining 
INFERENCE 
Annexin V conjugates with FITC (flurophore molecule) binds with phosphotidyl serine (PS) 
and causes loss of membrane integrity which leads to apoptosis. From this figure it is 
observed that at higher concentration there is more membrane blebbing which shows more 
apoptosis. (Fig-11) 
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Fig-11: Showing Annexin V-FITC staining in Hep-2 cell 
4.6. Caspase-3/7 Glo assay 
INFERENCE 
Apoptosis is a caspase dependent process, so that caspase-3/7 glo assay plays a major role in 
showing apoptosis. It was observed that the caspase activity increases accordingly with the 
increase of concentration of Con A. At higher concentration of con A i.e. 100µg/ml, more 
caspase activity is observed, which indicates more apoptosis. (Fig-12) 
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Fig-12: Graph showing % of caspase activity in Hep-2 cell post Con A treatment  
4.7. Inhibition of autophagy by chloroquine  inhibits Con A induced cell 
death 
 
 
Fig-13: Observation of chloroquine (CQ) and Con A treatment in Hep-2 cell 
38 
 
INFERENCE 
Chloroquine (CQ) is an autophagic inhibitor which inhibits autophagy. When CQ is added to 
the cells it was seen that there is no more cell death occurring and the cell death is same as 
the control. But when Con A is treated to the cells it was observed that highest number of cell 
death occurs. In last case when both CQ and Con A were treated to the cells, the number of 
dead cells decreses as compared to con A. Thus it indicates that CQ inhibits Con A induced 
cell death. (Fig-13) 
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CONCLUSION 
The above study has shown that Con A plays a major role in both apoptosis and autophagy. 
From acridine orange staining it was confirmed that Con A induces autophagy in Hep-2 cells. 
Annexin V FITC staining, DAPI staining and Caspase-3/7 Glo Assay demonstrate that Con A 
triggered Apoptosis in Hep-2 cells. Above study also shown that CQ inhibits Con A induced 
cell death. Hence, from the above discussion it was conclude that Con A-induces autophagy 
followed to apoptosis in oral cancer. Therefore, open up a new perspective for Con A as 
potential anti-cancer drug for future Oral cancer therapeutics. 
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